Corcept Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Corcept Therapeutics Inc.
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
Frequently asked questions
To buy Corcept Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Corcept Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Corcept Therapeutics Inc. is CORT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Corcept Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Corcept Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Corcept Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Corcept Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Corcept Therapeutics Inc..